36
Participants
Start Date
January 31, 2012
Primary Completion Date
August 31, 2012
Study Completion Date
May 31, 2013
LEISH-F3 + GLA-SE
20 ug of LEISH-F3 and 2 ug of GLA-SE adjuvant. 3 injections at Days 0, 28, and 56.
LEISH-F3 + GLA-SE
20 ug of LEISH-F3 and 5 ug of GLA-SE adjuvant. 3 injections at Days 0, 28, and 56.
LEISH-F3 alone
20 ug of LEISH-F3 antigen alone. 3 injections at Days 0, 28, and 56.
Comprehensive Clinical Development NW, Inc., Tacoma
Access to Advanced Health Institute (AAHI)
OTHER